CEACAM5 and malignant colon neoplasm: In addition, a considerable prognostic factor certified by this study was CEA, which is a well-established biomarker for colon cancer recommended by both the American Society of Clinical Oncology (ASCO) and the European Group on Tumor Markers (EGTM) [18–20].